AGT and acute kidney injury: In the case of SA-AKI, several large multicenter trials have looked at traditional drugs such as norepinephrine (norepinephrine), epinephrine, vasopressin, and dopamine, as well as more novel drugs such as angiotensin II and levosimendan (49).